CLINICAL_TRIALS
trial_result
· 2014-01-10
Clinical Trial Update: ESSENTIAL-"The Studies of Oral Enoximone Therapy in Advanced Heart Failure" [Phase 3]
Summary
A Phase 3 trial evaluating oral enoximone therapy for advanced heart failure has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Gilead Sciences | Conditions: Heart Failure, Congestive | Phase 3 | Status: TERMINATED